NRIX — Nurix Therapeutics Share News
0.000.00%
- $2.73bn
- $1.68bn
- $83.98m
Brief: Nurix Therapeutics To Offer And Sell $300 Mln Of Common Stock
Brief: Nurix Therapeutics Announces Presentations At The 7Th Annual Tpd & Induced Proximity Summit
Jefferies initiates Nurix Therapeutics with "buy", sets Street-high PT
Jefferies initiates Nurix Therapeutics with "buy", sets Street-high PT
U.S. RESEARCH ROUNDUP-Armada Hoffler Properties, Morphic Holding, Solid Biosciences
Nurix Therapeutics Inc reports results for the quarter ended in May - Earnings Summary
Brief: Nurix Therapeutics Inc Files For Common Stock Offering Of Up To $150 Million - SEC Filing
Nurix Therapeutics Inc expected to post a loss of 63 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Aerovate Therapeutics, Boeing, Wingstop
U.S. RESEARCH ROUNDUP-Brighthouse Financial, Microsoft, Shattuck Labs
Brief: Nurix Therapeutics Intends To Advance Nx-5948 Into Pivotal Trial In 2025
Brief: Nurix Therapeutics Inc Files For Mixed Shelf Size Not Disclosed - SEC Filing
Brief: Nurix Therapeutics Announces Board Chair Transition
U.S. STOCKS ON THE MOVE-Virco, Argan, State Street
U.S. STOCKS ON THE MOVE-Exxon, Oil stocks, Nextplat
U.S. STOCKS ON THE MOVE-Netflix, Citigroup, silver miners
Nurix Therapeutics drops after upsized $175 mln stock offering
Brief: Nurix Therapeutics Announces Pricing Of Upsized $175 Mln Public Offering
Nurix Therapeutics Inc reports results for the quarter ended in February - Earnings Summary